{"brief_title": "Juvenile Rheumatoid Arthritis", "brief_summary": "The purpose of this study is to determine the safety of anakinra in patients with Polyarticular-Course Juvenile Rheumatoid Arthritis, a form of rheumatoid arthritis affecting children.", "condition": ["Juvenile Chronic Arthritis"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["Anakinra", "Placebo"], "description": ["anakinra", "placebo"], "arm_group_label": ["anakinra", "placebo"], "criteria": "- Male or female age 2-17 yrs inclusive * Minimum weight 10 KG * Diagnosis of Chronic Arthritis", "gender": "All", "minimum_age": "2 Years", "maximum_age": "17 Years", "healthy_volunteers": "No", "mesh_term": ["Arthritis", "Arthritis, Rheumatoid", "Arthritis, Juvenile", "Interleukin 1 Receptor Antagonist Protein"], "id": "NCT00037648"}